I have come to the conclusion that Cyberpunk 2077 is my favorite video game of all time. I do not say that lightly, and it appears some people have also figured out just how good the game has become.

With 5,381 people listed in its credits, CD Projekt Red’s Cyberpunk 2077 is one of the game industry’s largest productions to date. And as it turns out, almost half of those people contributed ...

Following the successful release of Cyberpunk 2077’s Phantom Liberty DLC and update 2.0, CDPR announced Project Orion, a sequel to the AAA title. Cyberpunk 2077's Patch 2.2, released about a ...

Johnson & Johnson has opened the J.P. Morgan Healthcare Conference with a bang, buying out Intra-Cellular Therapies for $14.6 billion. At $132 per share, J&J paid a 39% premium on Friday’s ...

Intra-Cellular Therapies (ITCI) shares soared 14.9% in the last trading session to close at $94.87. The move was backed by solid volume with far more shares changing hands than in a normal session.

Johnson & Johnson said Monday it would buy Intra-Cellular Therapies in a deal worth $14.6 billion, another sign of large drugmakers’ reentry into neuroscience and a sizable purchase that will ...

Two new “pioneering” open-access scale-up facilities focused on advancing cellular agriculture are at the centre of a €12.5m investment grant from the Dutch National Growth Fund for Cellular ...

Rebel Wolves, a new studio filled with designers who previously worked on Cyberpunk 2077 and The Witcher 3 at CD Projekt Red, has formally revealed and titled its debut open-world vampire RPG ...

(RTTNews) - Johnson & Johnson (JNJ) and Intra-Cellular Therapies, Inc. (ITCI) announced Monday that they have entered into a definitive agreement under which Johnson & Johnson will acquire all ...

What are the best Cyberpunk 2077 mods? CD Projekt Red released its own REDmod tools for free, allowing everyone to install Cyberpunk 2077 mods through a dedicated client they can download from ...

(Reuters) - Johnson & Johnson said on Monday it would buy neurological drug maker Intra-Cellular Therapies for $14.6 billion, its biggest deal in more than two years, boosting its presence in the ...